Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Denies Petition Seeking Freeze On Russian Companies’ Regulatory Activities

Sep 02 2022

• By Derrick Gingery

Russia-Ukraine war — Multiple trade groups requested that pharmaceuticals be exempt from sanctions after Russian invaded Ukraine. • Source: Shutterstock

Related Content

Drugs From Sponsors ‘Located in Russia,’ Would Be Barred From US FDA Review By House Funding Bill

Jun 24 2022

Fears For Ukraine’s Access To Medicines And Trials As Russian Invasion Continues

Feb 25 2022

Ex-US FDA Official Petitions Agency To Stop Reviewing Applications From Russian Companies Amid War In Ukraine

Feb 25 2022

Renewed Political Pressure on Hydroxychloroquine for COVID Highlights Need For Independent US FDA

Jul 08 2020

US COVID-19 Vaccine Booster Plan Also Boosts Pressure On FDA

Aug 18 2021

US FDA’s Foreign Data Policy Faces Its Greatest Test From Chinese PD-1/L1 Inhibitors

Dec 16 2021

Biotech CEOs Take Assertive Stance On Ukraine War, While PhRMA Remains More Neutral

Mar 01 2022

Sputnik COVID-19 Vaccine Caught Up In Sanctions On Russia Over Ukraine Invasion

Mar 01 2022

Related Companies

Pfizer Inc.

BioNTech SE

Moderna, Inc.

Bluebird Bio

Additional Topics

United States Russian Federation Europe Ukraine FDA Review Pathway Regulation Dietary Supplements OTC Drugs BioPharmaceutical

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.